Skip to main content
SunBio, Inc. logo

SunBio, Inc. — Investor Relations & Filings

Ticker · 067370 ISIN · KR7067370007 KO Manufacturing
Open in API
Filings indexed 213 across all filing types
Latest filing 2020-12-14 Director's Dealing
Country KR South Korea
Listing KO 067370

About SunBio, Inc.

http://www.sunbio.com/

SunBio, Inc. is a biotechnology company that develops biosimilars, biopharmaceuticals, and medical devices. The company's core activities are based on its proprietary PEGylation technology, a process that modifies molecules to enhance their therapeutic properties. SunBio's product portfolio includes PEG reagents for research and drug delivery, as well as biopharmaceutical candidates. Key development projects include MucoPEG™, a muco-adhesive hydrogel, and SBX, an artificial blood substitute. The company positions itself as a specialist in PEGylation, creating advanced therapeutic products for a global market.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. It details the share transactions (specifically '장내매수' or on-market purchases) by an executive (CEO Noh Kwang) of SunBio Co., Ltd. This type of filing is a standard regulatory disclosure for insider trading/shareholding changes by company directors, which corresponds to the 'Director's Dealing' category.
2020-12-14 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory notice regarding the suspension of share registration (closing of the shareholder register) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal regulatory announcement of a corporate action. Given it does not fit into specific categories like dividend announcements or share buybacks, it falls under the general regulatory filing category.
2020-12-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/Korea Exchange). This document details the shareholdings and specific transactions (purchases) made by a company director (CEO). In the context of financial filings, reports detailing personal share transactions by company directors and executives are classified as 'Director's Dealing'.
2020-12-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is titled '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is the standard Korean regulatory filing for disclosing significant changes in share ownership (often referred to as the 5% rule). It details the reporting entity, special related parties, changes in shareholding percentages, and the reasons for these changes (e.g., stock sales, repayment of collateral loans). This fits the definition of a 'Major Shareholding Notification'.
2020-11-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the changes in share ownership by a company executive (No Kwang) of SunBio Co., Ltd. due to the repayment of stock-collateralized loans. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) in the provided taxonomy, as it reports personal share transactions by company directors/executives.
2020-11-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service and Korea Exchange. It details specific share transactions (sales) by a director/major shareholder (Nho Kwang) of Sunbio Co., Ltd. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports personal share transactions by company insiders.
2020-11-09 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.